Breaking News Instant updates and real-time market news.

ADI

Analog Devices

$79.75

-1.19 (-1.47%)

19:41
06/15/17
06/15
19:41
06/15/17
19:41

Analog Devices initiated with a Market Perform at Raymond James

Raymond James analyst Chris Caso resumed coverage on Analog Devices with a Market Perform saying earnings and cash flow post linear are in line peers.

  • 20

    Jun

ADI Analog Devices
$79.75

-1.19 (-1.47%)

06/14/17
RHCO
06/14/17
NO CHANGE
RHCO
Analog Devices to forecast double digit EPS growth, says SunTrust
SunTrust analyst William Stein expects Analog Devices to unveil "a new business model" that will include EPS growth of at least 10% at its Analyst Day next Tuesday. He thinks that more investors will believe that the stock deserves its current premium following the Analyst Day. Stein keeps a $101 price target and a Buy rating on the shares.
06/07/17
RBCM
06/07/17
NO CHANGE
RBCM
Analog Devices weakness will be short lived, says RBC Capital
RBC Capital analyst Amit Daryanani notes that Analog Devices (ADI) "has underperformed rather notably" since its Q2 results on May 31. The analyst blames the weakness on the company's reduced revenue from Apple (AAPL). However, he thinks that investors will begin focusing more on the company's multiple tailwinds, possibly starting in the wake of its June 20 Analyst Day. Consequently, he expects the stock to rise from current levels and keeps a $92 price target and Outperform rating on the shares.
06/06/17
MSCO
06/06/17
NO CHANGE
MSCO
Analog Devices shares should advance, says Morgan Stanley
Morgan Stanley analyst Craig Hettenbach expects Analog Devices' stock to rise, driven by the "strength" of its "core business" and accretion from its acquisition of Linear. Although analysts didn't raise their estimates for the company due to its declining revenue per iPhone, there is now a better chance that its multiple will increase based on its lower customer concentration and increasing gross margins, according to Hettenbach. The analyst keeps a $96 price target and an Overweight rating on the stock.
06/02/17
06/02/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. ADP (ADP) downgraded to Underperform from In Line at Evercore ISI with analyst David Togut saying the firm's Payroll Manager Survey indicates softer demand and rising client losses at ADP. 2. Workday (WDAY) downgraded to Neutral from Buy at BTIG with analyst Joel Fishbein saying the company reported a "good" quarter, but high expectations are reflected in valuation. 3. Analog Devices (ADI) downgraded to Reduce from Neutral at Nomura Instinet with analyst Romit Shah saying he believes shares are overvalued and the Street may be too optimistic about the quality of Analog's franchise saying third quarter guidance was "very mixed" and implies the company missed on margins, a key part of the bull case. 4. Take-Two (TTWO) downgraded to Underperform from Neutral at Hilliard Lyons with analyst Jeffrey Thomison citing valuation. 5. Range Resources (RRC) downgraded to Buy from Conviction Buy at Goldman Sachs with analyst Brian Singer saying shares have underperformed since being added to the list on October 31, 2016 on the back of poor gas sentiment and reduced confidence in Louisiana assets acquired in 2016 due to unfavorable well performance and a shift in how the company plans to flow future wells. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

IPAS

iPass

$0.45

-0.0349 (-7.21%)

07:53
01/17/18
01/17
07:53
01/17/18
07:53
Initiation
iPass initiated  »

iPass initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BYD

Boyd Gaming

$36.16

-0.32 (-0.88%)

07:51
01/17/18
01/17
07:51
01/17/18
07:51
Initiation
Boyd Gaming initiated  »

Boyd Gaming initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GSK

GlaxoSmithKline

$37.92

0.42 (1.12%)

, NURO

NeuroMetrix

$1.72

-0.06 (-3.37%)

07:51
01/17/18
01/17
07:51
01/17/18
07:51
Technical Analysis
Technical Take: NeuroMetrix up sharply, GlaxoSmithKline strategic collaboration »

NeuroMetrix (NURO) was…

GSK

GlaxoSmithKline

$37.92

0.42 (1.12%)

NURO

NeuroMetrix

$1.72

-0.06 (-3.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

  • 25

    Mar

  • 23

    Apr

MOBL

MobileIron

07:51
01/17/18
01/17
07:51
01/17/18
07:51
Initiation
MobileIron initiated  »

MobileIron initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PPG

PPG

$116.64

-1.53 (-1.29%)

07:51
01/17/18
01/17
07:51
01/17/18
07:51
Downgrade
PPG rating change  »

PPG downgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

JEC

Jacobs Engineering

$69.42

-0.14 (-0.20%)

07:51
01/17/18
01/17
07:51
01/17/18
07:51
Hot Stocks
Jacobs wins engineering services agreement from Carcross/Tagish Energy »

Jacobs Engineering Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 07

    Feb

07:50
01/17/18
01/17
07:50
01/17/18
07:50
Conference/Events
UBS REITs analyst holds an analyst/industry conference call »

REITs Analyst Yulico,…

GM

General Motors

$44.19

0.12 (0.27%)

07:49
01/17/18
01/17
07:49
01/17/18
07:49
Periodicals
GM, DHL use Chinese plant to handle flow of parts, Reuters reports »

DHL employees have been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

EGAN

eGain

$5.35

-0.35 (-6.14%)

07:48
01/17/18
01/17
07:48
01/17/18
07:48
Initiation
eGain initiated  »

eGain initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$221.53

0.3 (0.14%)

07:48
01/17/18
01/17
07:48
01/17/18
07:48
Recommendations
Netflix analyst commentary  »

Netflix checks suggest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

  • 22

    Jan

  • 30

    Jan

XRAY

Dentsply Sirona

$65.65

-0.14 (-0.21%)

07:47
01/17/18
01/17
07:47
01/17/18
07:47
Hot Stocks
Dentsply Sirona adds three new board members »

Dentsply Sirona has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:47
01/17/18
01/17
07:47
01/17/18
07:47
General news
Futures suggest rebound from yesterday's dip »

Stock futures are higher…

PSO

Pearson

$9.82

-0.08 (-0.81%)

07:47
01/17/18
01/17
07:47
01/17/18
07:47
Hot Stocks
Pearson: U.S. tax reform to result in one-off deferred tax charge in 2017 »

Pearson says, "Our…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PSO

Pearson

$9.82

-0.08 (-0.81%)

07:46
01/17/18
01/17
07:46
01/17/18
07:46
Hot Stocks
Pearson sees FY18 adjusted operating profit GBP520M-GBP560M »

Pearson says, "In…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIFI

Boingo Wireless

$21.49

-0.83 (-3.72%)

07:46
01/17/18
01/17
07:46
01/17/18
07:46
Initiation
Boingo Wireless initiated  »

Boingo Wireless initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

PSO

Pearson

$9.82

-0.08 (-0.81%)

07:46
01/17/18
01/17
07:46
01/17/18
07:46
Earnings
Pearson sees FY adjusted EPS above 49p-52p guidance range »

Adjusted earnings per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADNT

Adient

$81.91

-0.51 (-0.62%)

07:45
01/17/18
01/17
07:45
01/17/18
07:45
Technical Analysis
Technical Take: Adient falls sharply in pre-market, analyst action »

Shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

ESPR

Esperion

$71.91

-1.35 (-1.84%)

07:45
01/17/18
01/17
07:45
01/17/18
07:45
Recommendations
Esperion analyst commentary  »

Esperion price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEN

Lennar

$68.78

-0.48 (-0.69%)

07:44
01/17/18
01/17
07:44
01/17/18
07:44
Recommendations
Lennar analyst commentary  »

Lennar price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NHYDY

Norsk Hydro

$7.60

-0.16 (-2.06%)

07:43
01/17/18
01/17
07:43
01/17/18
07:43
Downgrade
Norsk Hydro rating change  »

Norsk Hydro downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FAST

Fastenal

$55.44

-0.15 (-0.27%)

07:43
01/17/18
01/17
07:43
01/17/18
07:43
Earnings
Fastenal reports Q4 EPS 45c ex-tax benefit, consensus 45c »

Management said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

LBTYA

Liberty Global

$36.56

-0.31 (-0.84%)

07:43
01/17/18
01/17
07:43
01/17/18
07:43
Upgrade
Liberty Global rating change  »

Liberty Global upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JUNO

Juno Therapeutics

$45.60

-3.15 (-6.46%)

, CELG

Celgene

$104.82

-1.18 (-1.11%)

07:42
01/17/18
01/17
07:42
01/17/18
07:42
Recommendations
Juno Therapeutics, Celgene analyst commentary  »

Juno Therapeutics price…

JUNO

Juno Therapeutics

$45.60

-3.15 (-6.46%)

CELG

Celgene

$104.82

-1.18 (-1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 25

    Jan

  • 25

    Jan

  • 16

    Feb

  • 25

    Mar

GS

Goldman Sachs

$258.46

1.43 (0.56%)

07:42
01/17/18
01/17
07:42
01/17/18
07:42
Hot Stocks
Goldman CEO: Global economy poised to accelerate, tax reform providing tailwinds »

"Last year, we…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 18

    Jan

  • 31

    Jan

ONTX

Onconova

$1.74

-0.0901 (-4.92%)

07:42
01/17/18
01/17
07:42
01/17/18
07:42
Hot Stocks
Onconova increases sample size in Phase 3 INSPIRE pivotal trial in MDS »

Onconova is moving…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.